These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 31332712)
21. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma. Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127 [TBL] [Abstract][Full Text] [Related]
22. Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer. Tan J; Qian X; Song B; An X; Cai T; Zuo Z; Ding D; Lu Y; Li H Oncol Rep; 2018 Jul; 40(1):111-122. PubMed ID: 29749483 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer. Tan J; Liu L; Zuo Z; Song B; Cai T; Ding D; Lu Y; Ye X Oncol Rep; 2020 Oct; 44(4):1489-1501. PubMed ID: 32945494 [TBL] [Abstract][Full Text] [Related]
24. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis. Qu T; Li YP; Li XH; Chen Y Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685 [TBL] [Abstract][Full Text] [Related]
25. Identification of Zhang Y; Xie X; Zhou H; Li B; Ding L; Cai Z; Song H; Zhao S; Xu H Front Endocrinol (Lausanne); 2023; 14():1131078. PubMed ID: 37455914 [TBL] [Abstract][Full Text] [Related]
26. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition. Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662 [TBL] [Abstract][Full Text] [Related]
27. Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma. Han J; Chen M; Wang Y; Gong B; Zhuang T; Liang L; Qiao H Sci Rep; 2018 Jul; 8(1):9912. PubMed ID: 29967488 [TBL] [Abstract][Full Text] [Related]
28. Identification of potential targetable genes in papillary, follicular, and anaplastic thyroid carcinoma using bioinformatics analysis. Agarwal S; Gupta S; Raj R Endocrine; 2024 Oct; 86(1):255-267. PubMed ID: 38676768 [TBL] [Abstract][Full Text] [Related]
29. Key candidate genes associated with BRAF Yu X; Zhong P; Han Y; Huang Q; Wang J; Jia C; Lv Z J Cell Physiol; 2019 Dec; 234(12):23369-23378. PubMed ID: 31161615 [TBL] [Abstract][Full Text] [Related]
30. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847 [TBL] [Abstract][Full Text] [Related]
31. A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database. Wang M; Li R; Zou X; Wei T; Gong R; Zhu J; Li Z Medicine (Baltimore); 2020 Aug; 99(35):e21996. PubMed ID: 32871952 [TBL] [Abstract][Full Text] [Related]
32. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma. Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496 [TBL] [Abstract][Full Text] [Related]
33. Naive and regulatory B-cell transcription patterns guide the increased risk of papillary thyroid carcinoma in obesity. Yu Z; Xu Z; Li S; Tian Z; Yuan J Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):118-126. PubMed ID: 38678617 [TBL] [Abstract][Full Text] [Related]
34. Identification and validation of potential common biomarkers for papillary thyroid carcinoma and Hashimoto's thyroiditis through bioinformatics analysis and machine learning. Jiang H; He Y; Lan X; Xie X Sci Rep; 2024 Jul; 14(1):15578. PubMed ID: 38971817 [TBL] [Abstract][Full Text] [Related]
35. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
36. TPO as an indicator of lymph node metastasis and recurrence in papillary thyroid carcinoma. Li X; Cheng R Sci Rep; 2023 Jul; 13(1):10848. PubMed ID: 37407700 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive Identification of Potential Crucial Genes and miRNA-mRNA Regulatory Networks in Papillary Thyroid Cancer. Nan BY; Xiong GF; Zhao ZR; Gu X; Huang XS Biomed Res Int; 2021; 2021():6752141. PubMed ID: 33521130 [TBL] [Abstract][Full Text] [Related]
39. The prognostic potential of alpha-1 type I collagen expression in papillary thyroid cancer. Huang C; Yang X; Han L; Fan Z; Liu B; Zhang C; Lu T Biochem Biophys Res Commun; 2019 Jul; 515(1):125-132. PubMed ID: 31128912 [TBL] [Abstract][Full Text] [Related]
40. [Bioinformatic analysis of CCND2 expression in papillary thyroid carcinoma and its impact on immune infiltration]. Wang Q; Song B; Hao S; Xiao Z; Jin L; Zheng T; Chai F Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):981-988. PubMed ID: 38862457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]